Histopathology Core-Shared Resources

组织病理学核心共享资源

• 批准号: 9761997
• 负责人: XIAOXIN Luke CHEN
• 金额: $ 20.06万
• 依托单位: NORTH CAROLINA CENTRAL UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至 2023-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9761997
• 关键词: Applications Grants; Archives; Area; Biotechnology; Cancer Center Planning Grant; Cell Culture System; Comprehensive Cancer Center; Data; Data Analyses; Diagnostic; Diagnostic Services; Education; Educational workshop; Ensure; Environment; Equipment; Experimental Designs; Formalin; Funding; Future; Genes; Goals; Grant; Histopathology; Histopathology Facility; Hospitals; Human Resources; Image Analysis; Laboratories; Laboratory Research; Microarray Analysis; Molecular; National Institute of General Medical Sciences; North Carolina; Paraffin Embedding; Pilot Projects; Postdoctoral Fellow; Publications; Publishing; Research; Research Activity; Research Institute; Research Personnel; Research Project Grants; Resource Sharing; Sampling; Services; Solid; Students; Supervision; Surgical Pathology; Techniques; Tissue Microarray; Tissue Sample; Tissue imaging; Training; Training and Education; Translational Research; United States National Institutes of Health; Universities; Validation; Writing; animal tissue; anticancer research; cancer health disparity; health disparity; human tissue; in vivo; instrument; member; minority student; next generation sequencing; pyrosequencing; quantitative imaging; student training; success

Abstract With the support of NIH/NCI U54 grant (CA156735) and NIH/NIGMS P20 grant (MD000175), we have designated space and essential instruments to establish a Diagnostic and Molecular Histopathology Facility (DMHF) at the Julius L. Chambers Biomedical/Biotechnology Research Institute (BBRI) of the North Carolina Central University (NCCU). In this renewal U54 partnership between NCCU and Lineberger Comprehensive Cancer Center (LCCC), our DMHF has Specific Aims as follows: (1) To further develop a diagnostic and molecular histopathology laboratory; (2) To provide histopathological service to research projects in this grant proposal and other health disparity studies; (3) To support publications and grant applications when histopathology expertise is needed; and (4) To train students, postdocs and technical staff members to use histopathological techniques for both research and educational purposes. In summary, the DMHF is expected to provide solid technical support to research projects (Full Project 1, Full Project 3 and Pilot Project 2) and education during the U54 grant period and in the future. The goal is to ensure the partnership in cancer disparity research between NCCU and LCCC a success.

抽象的 在NIH/NCI U54 Grant（CA156735）和NIH/NIGMS P20 Grant（MD000175）的支持下，我们有 指定的空间和基本仪器来建立诊断和分子组织病理学设施 （DMHF）在北卡罗来纳州的朱利叶斯·钱伯斯生物医学/生物技术研究所（BBRI） 中央大学（NCCU）。在NCCU与Lineberger综合之间的这种续签U54合作伙伴关系中 癌症中心（LCCC），我们的DMHF具有以下特定目的：（1）进一步发展诊断和 分子组织病理学实验室； （2）为该赠款中的研究项目提供组织病理学服务 提案和其他健康差异研究； （3）在 需要组织病理学专业知识； （4）培训学生，博士后和技术人员使用 用于研究和教育目的的组织病理学技术。总之，预计DMHF 为研究项目提供可靠的技术支持（完整项目1，完整项目3和Pilot Project 2）和 U54赠款期和将来的教育。目标是确保癌症的伙伴关系 NCCU与LCCC之间的差异研究成功。